After Several Months of Providing Requested Inform
Post# of 148165
After Several 12 Hour Days of Consulting withLawyers, Cytodyn's CEO Issues Press Release About Enrolling Patients in in its Current Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms in the UK at Some Time in the Future
Not yet though.